Targeting enabled homolog with daunorubicin inhibits ERK1/2/c‐Fos pathway and suppresses hepatocellular carcinoma progression - Zhi‐Mei Li; Guan Liu; Qing‐Qing Liu; Wei‐Ming You; Ming‐Gao Zhao (Clinical and Translational Medicine)